Aberdeen Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-35,127
Closed -$3.13M 772
2017
Q1
$3.13M Buy
35,127
+3,416
+11% +$281K 0.01% 526
2016
Q4
$2.24M Sell
31,711
-3,056
-9% -$228K 0.01% 555
2016
Q3
$2.75M Sell
34,767
-6,706
-16% -$572K 0.01% 539
2016
Q2
$3.76M Buy
41,473
+2,774
+7% +$235K 0.01% 467
2016
Q1
$3.29M Sell
38,699
-4,079
-10% -$303K 0.01% 488
2015
Q4
$3.39M Buy
42,778
+8,170
+24% +$644K 0.01% 482
2015
Q3
$2.44M Buy
34,608
+2,580
+8% +$212K 0.01% 487
2015
Q2
$2.89M Sell
32,028
-1,939
-6% -$187K 0.01% 470
2015
Q1
$3.42M Sell
33,967
-3,187
-9% -$321K 0.01% 448
2014
Q4
$3.73M Sell
37,154
-115,664
-76% -$11.5M 0.01% 433
2014
Q3
$14.7M Sell
152,818
-36,862
-19% -$3.49M 0.03% 251
2014
Q2
$17.7M Buy
189,680
+151,900
+402% +$13.3M 0.04% 242
2014
Q1
$3.14M Buy
37,780
+16,300
+76% +$1.32M 0.01% 259
2013
Q4
$1.79M Hold
21,480
0.01% 325
2013
Q3
$1.6M Sell
21,480
-1,990
-8% -$149K ﹤0.01% 342
2013
Q2
$1.86M Buy
+23,470
New +$1.88M 0.01% 311

Other funds holding MJN

Aberdeen Asset Management's MJN Position: Q2 2017 in Review

Aberdeen Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 35,127 shares — an estimated $3.13M sold.

Aberdeen Asset Management first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $17.7M in Q2 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Aberdeen Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Aberdeen Asset Management sold 35,127 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $3.13M.
  • Aberdeen Asset Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Aberdeen Asset Management's Mead Johnson Nutrition Company position peaked at $17.7M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.